Tracking CD206+ Macrophages with MRI and Fluorescence Imaging
Author Information
Author(s): Wang Cuihua, Jalali Motlagh Negin, Wojtkiewicz Gregory R., Yang Hongzhi, Kim Hyung-Hwan, Chen John W.
Primary Institution: Massachusetts General Hospital
Hypothesis
Can a multi-mannose approach effectively develop agents to specifically detect and monitor CD206+ macrophages in various disease conditions?
Conclusion
The study successfully developed imaging agents that can specifically track CD206+ macrophages in models of wound healing, glioma, and stroke.
Supporting Evidence
- CD206+ macrophages play key roles in the immune response and are promising targets for diagnostics and therapy.
- The developed agents showed high specificity for CD206+ macrophages in various disease models.
- Imaging results correlated well with flow cytometry data, confirming the agents' effectiveness.
- MannGdFish demonstrated favorable pharmacokinetics and biodistribution, making it a promising candidate for clinical use.
Takeaway
Scientists created special agents that can find and follow certain immune cells in the body, helping to see how they work in healing wounds and fighting tumors.
Methodology
The study involved designing and synthesizing fluorescent and MRI agents, followed by in vitro and in vivo testing in various disease models.
Potential Biases
Potential conflicts of interest due to financial interests of authors in related companies.
Limitations
The synthesis of imaging agents with more than two mannose units is challenging, and other cell types also express CD206, which may affect specificity.
Participant Demographics
Mice models including C57BL/6J, Mrc1+/+, Mrc1+/-, and Mrc1-/- were used.
Statistical Information
P-Value
p = 0.007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website